Safety
GHK-Cu
Adverse-event report summary for GHK-Cu, drawn from the FDA Adverse Event Reporting System (FAERS).
- Total reports
- 2
- Reports flagged serious
- 2
“Serious” is FAERS’s own report-level flag (e.g. death, hospitalization, or another outcome the reporter marked as serious) and does not indicate a verified or compound-caused outcome.
Most frequently reported reactions
- Adverse Drug Reaction1 reports
- Anaphylactic Shock1 reports
- Blood Pressure Decreased1 reports
- Flushing1 reports
- Heart Rate Decreased1 reports
- Hyperhidrosis1 reports
- Hypersensitivity1 reports
- Immobile1 reports
- Loss Of Consciousness1 reports
- Malignant Lymphoid Neoplasm1 reports
- Pallor1 reports
- Product Dispensed By Unauthorised Provider1 reports
- Syncope1 reports
- Vision Blurred1 reports
Counts reflect the most-reported reaction terms (MedDRA preferred terms) associated with reports naming this compound. A single report can list multiple reactions, so reaction counts need not sum to the total number of reports.